Trueblue Stock Price, News & Analysis (NYSE:TBI)

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its board has authorized a share repurchase plan on Tuesday, October 31st 2017, which allows the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company's management believes its shares are undervalued.

Trueblue Inc (NYSE:TBI) posted its quarterly earnings data on Monday, July, 29th. The business services provider reported $0.64 EPS for the quarter, topping the consensus estimate of $0.58 by $0.06. The business services provider had revenue of $588.59 million for the quarter, compared to analyst estimates of $615.94 million. Trueblue had a net margin of 2.71% and a return on equity of 15.36%. The business's revenue was down 4.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.57 earnings per share. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, October 28th 2019. View Earnings Estimates for Trueblue.

Trueblue will be holding an earnings conference call on Monday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Trueblue updated its third quarter earnings guidance on Monday, July, 29th. The company provided earnings per share (EPS) guidance of $0.61-0.71 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $613-638 million, compared to the consensus revenue estimate of $683.26 million.

4 brokers have issued 1 year price objectives for Trueblue's shares. Their forecasts range from $22.00 to $26.00. On average, they expect Trueblue's stock price to reach $24.25 in the next year. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Price Targets for Trueblue.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Trueblue.

News headlines about TBI stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trueblue earned a media sentiment score of -1.9 on InfoTrie's scale. They also assigned news articles about the business services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Trueblue.

Trueblue saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 574,900 shares, a drop of 24.5% from the August 30th total of 761,800 shares. Based on an average trading volume of 218,500 shares, the short-interest ratio is presently 2.6 days. Currently, 1.5% of the shares of the stock are short sold. View Trueblue's Current Options Chain.

Some companies that are related to Trueblue include ASGN (ASGN), AMN Healthcare Services (AMN), TTEC (TTEC), Kelly Services (KELYB), Kelly Services (KELYA), Kforce (KFRC), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), Command Center (CCNI), DLH (DLHC), R C M Technologies (RCMT), Hudson Global (HSON) and Staffing 360 Solutions (STAF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Trueblue investors own include Intel (INTC), Goldman Sachs Group (GS), Square (SQ), First Bancshares (FBMS), Micron Technology (MU), Neurocrine Biosciences (NBIX), NVIDIA (NVDA), Roku (ROKU), RealPage (RP) and SpartanNash (SPTN).

Trueblue's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.25%), State of Alaska Department of Revenue (0.08%), Envestnet Asset Management Inc. (0.07%), Alpha Windward LLC (0.05%), Pacer Advisors Inc. (0.05%) and Nisa Investment Advisors LLC (0.03%). Company insiders that own Trueblue stock include A Patrick Beharelle, Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Jeffrey B Sakaguchi, Joseph P Sambataro Jr, Sean A Ebner, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have sold Trueblue company stock in the last year include A Patrick Beharelle, Derrek Lane Gafford, James E Defebaugh, Jeffrey B Sakaguchi and Taryn R Owen. View Insider Buying and Selling for Trueblue.

TBI stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., State of Alaska Department of Revenue, Meeder Asset Management Inc., Pacer Advisors Inc., Alpha Windward LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $22.12.

Trueblue has a market capitalization of $886.35 million and generates $2.50 billion in revenue each year. The business services provider earns $65.75 million in net income (profit) each year or $2.28 on an earnings per share basis. Trueblue employs 6,700 workers across the globe.View Additional Information About Trueblue.

The official website for Trueblue is http://www.trueblue.com/.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]